Global Conferences RLT Education RLT Components Sponsors Trial Stats 
Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment (SPLASH)
Description:
The purpose of this study is to evaluate the efficacy and safety of [Lu-177]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT).
Sponsor:
Point BiopharmaGovernment Study Link:
NCT04647526 - Click here to see study onClinicalTrials.gov
Patient Education
Patient Education Not Yet Provided
Publications
Publications Not Yet Provided
Locations
XCancer - Omaha
17607 Gold Plaza, Omaha, Nebraska 68130, United States
Principal Investigator
Luke T. Nordquist, MD
John Cohchran VA St. Louis Health Care System
St. Louis, Missouri, United States
Greater Dayton Cancer Center
Kettering, Ohio, United States
University of Colorado Hospital
Aurora, Colorado, United States
Astera Cancer Care
East Brunswick, New Jersey, United States
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
University of Michigan Hospitals
Ann Arbor, Michigan, United States
Tri-State Urologic Services
Cincinnati, Ohio, United States
University of Kentucky Chandler Medical Center
Lexington, Kentucky, United States
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Tulane University Medical Center
New Orleans, Louisiana, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
University of California Los Angeles, Nuclear Medicine Clinic
Los Angeles, California, United States
Stanford Cancer Institute
Stanford, California 94305, United States
Washington University School of Medicine
St. Louis, Missouri, United States
Karmanos Cancer Institute
Detroit, Michigan, United States
Excel Diagnostics & Nuclear Oncology Center
Houston, Texas, United States
University of Iowa Medical Center
Iowa City, Iowa, United States
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
Swedish Cancer Institute Research
Seattle, Washington, United States
University of Maryland Greenebaum Cancer Center
Baltimore, Maryland, United States
University of Texas Southwestern Medical Center
Dallas, Texas 75390, United States
New Mexico Oncology Hematology Consultants Ltd., New Mexico Cancer Center
Albuquerque, New Mexico, United States
Dallas VA Medical Center, Nuclear Medicine Service
Dallas, Texas, United States
Chesapeake Urology Associates (CUA) P.A.
Towson, Maryland, United States
Saint Louis University Hospital
St. Louis, Missouri, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of California Irvine Chao Family Comprehensive Cancer Center
Orange, California, United States
Jewish General Hospital
Montréal, Quebec, Canada
BC Cancer - Vancouver
Vancouver, British Columbia, Canada
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
London Health Sciences Center - Victoria Hospital
London, Ontario, Canada
CHUM - University Hospital of Montreal
Montréal, Quebec, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
CHU of Quebec - Laval University
Québec, Quebec, Canada
Sunnybrook Research Institute, Odette Cancer Center
Toronto, Ontario, Canada
La Timone Hospital, Nuclear Medicine Department
Marseille, Bouches-du-RhĂ´ne, France
Center Jean Perrin, Department of Medical Oncology
Clermont-Ferrand, Puy-de-DĂ´me, France
Claude Huriez Hospital
Lille, Nord, France
Tenon Hospital, Department of Medical Oncology
Paris, France
Montpellier Cancer Institute, Department of Nuclear Medicine
Montpellier, HĂ©rault, France
St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands
Erasmus University Medical Center Rotterdam
3015 GD, Rotterdam, South Holland, Netherlands
Sahlgrenska University Hospital
Göteborg, Västra Götaland, Sweden
Norrlands University Hospital, Department of Radiation Sciences, Oncology
Umeå, Västerbotten, Sweden
Charing Cross Hospital, Department of Medical Oncology
Greater London, England, United Kingdom
Royal Marsden NHS Foundation Trust - Institute of Cancer Research
Sutton, Greater London, England, United Kingdom
